An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK)

NCT02856230 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lower Limb Ischemia
Peripheral Vascular Diseases

Interventions

DEVICE: Ranger SL DEB

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]